Eleonora Marostica

Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies

Eleonora Marostica, Juthamas Sukbuntherng, David Loury et al. · Cancer Chemotherapy and Pharmacology · 2014 · 73 citations

Hematological Malignancy, Population Pharmacokinetic Model, Medicine +9

PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients

Stefan Willmann, Eleonora Marostica, Nelleke Snelder et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 39 citations · Full text

Deconvolution‐based assessment of pituitary<scp>GH</scp>secretion stimulated with<scp>GHRH</scp>+arginine in<scp>P</scp>rader‐<scp>W</scp>illi adults and obese controls

Graziano Grugni, Eleonora Marostica, Antonino Crinò et al. · Clinical Endocrinology · 2013 · 15 citations

The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader–Willi syndrome shows age- and BMI-dependent and genotype-related differences

Eleonora Marostica, Graziano Grugni, Giuseppe De Nicolao et al. · Growth Hormone & IGF Research · 2013 · 15 citations

Pharmacokinetic and Pharmacodynamic Modelling to Characterize the Tolerability of Alternative Up-Titration Regimens of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease

Axel Facius, Eleonora Marostica, Philip Gardiner et al. · Clinical Pharmacokinetics · 2018 · 13 citations · Full text